✦ LIBER ✦

Role of interferon alfa-2b in the management of patients with advanced cutaneous T-cell lymphoma

✍ Scribed by Tariq I. Mughal

Book ID: 119157066
Publisher: Elsevier Science
Year: 1991
Weight: 232 KB
Volume: 27
Category: Article
ISSN: 0277-5379
DOI: 10.1016/0277-5379(91)90569-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The role of recombinant interferon alfa-

The role of recombinant interferon alfa-2a in the therapy of cutaneous t-cell lymphomas

✍ Paul A. Bunn Jr; Daniel C. Ihde; Kenneth A. Foon 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 725 KB

Low dosage alpha-interferon treatment in

Low dosage alpha-interferon treatment in patients with advanced cutaneous T-cell lymphoma

✍ H. Hagberg; L. Juhlin; A. Scheynius; U. Tjernlund 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 632 KB

Role of extracorporeal photochemotherapy

Role of extracorporeal photochemotherapy alone and in combinationwith interferon alfa in the treatment of cutaneous T-cell lymphoma

✍ Michele Fimiani; Pietro Rubegni; Giovambattista De Aloe; Lucio Andreassi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 214 KB

New Advances in the Management of Cutane

New Advances in the Management of Cutaneous T-Cell Lymphoma

✍ Sallie K. Young 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 355 KB

The role of interferon alfa 2b (IFN) as

The role of interferon alfa 2b (IFN) as maintenance therapy in patients with low-grade malignant lymphoma

✍ Aviles, A.; Talavera, A.; Garcia, E.; Mambo, M.J.; Diaz-Maqueo, J.C. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 152 KB

Results of a Phase II trial of oral bexa

Results of a Phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma

✍ David J. Straus; Madeleine Duvic; Timothy Kuzel; Steven Horwitz; Marie-France De 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

## Abstract ## BACKGROUND. Bexarotene is one of the most active single agents for the treatment of recurring or refractory cutaneous T‐cell lymphoma (CTCL). Interferon alfa has also been used for many years as an effective treatment for this disease. The results in recent case reports of the combi